DNA and macromolecules in normal brain tissue adjacent to the implant

The term DNA and macromolecules in normal brain tissue adjacent to the implant refers to the collective biological components of healthy brain parenchyma that are exposed to high concentrations of therapeutic agents or radiation following the placement of a localized medical device. This is most commonly discussed in the context of carmustine-impregnated wafers (Gliadel) or interstitial brachytherapy used to treat malignant gliomas (Brem et al., 1995). These macromolecules, including genomic DNA, structural proteins, and lipids, are not intended therapeutic targets but often sustain collateral damage as drugs diffuse from the implant site into the surrounding tissue (Fung et al., 1998). Such interactions can lead to non-specific alkylation and oxidative stress, which are primary drivers of local neurotoxicity and treatment-related complications like brain edema or necrosis (Westphal et al., 2003). Understanding the impact on these macromolecules is critical for balancing the efficacy of local tumor control with the preservation of neurological function in patients. Consequently, this site is a major focus for safety assessments in the development of intracranial drug delivery systems.

Other names

Peritumoral brain macromoleculesNormal brain tissue DNAAdjacent brain parenchymaHealthy brain tissue surrounding implant

Non-specific chemical modification including alkylation of DNA bases, formation of DNA-protein cross-links, and radiolytic damage to cellular membranes and proteins.